{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:44:58Z","timestamp":1793727898047,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health, Jiangsu, China","award":["ZKX21029"],"award-info":[{"award-number":["ZKX21029"]}]},{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2022-YXZX-GK-01"],"award-info":[{"award-number":["2022-YXZX-GK-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04475-6","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:05:23Z","timestamp":1767013523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Roxadustat on bone metabolism markers in patients with renal anemia"],"prefix":"10.1007","volume":"91","author":[{"given":"Jianglin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"4475_CR1","doi-asserted-by":"publisher","unstructured":"J.L. Babitt, M.F. Eisenga, V.H. Haase, A.V. Kshirsagar, A. Levin, F. Locatelli et al., Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 99, 1280-95 (2021). https:\/\/doi.org\/10.1016\/j.kint.2021.03.020","DOI":"10.1016\/j.kint.2021.03.020"},{"key":"4475_CR2","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.ajkd.2021.09.017","volume":"79","author":"JW Bazeley","year":"2022","unstructured":"J.W. Bazeley, J.B. Wish, Recent and emerging therapies for iron deficiency in anemia of CKD: A review. Am. J. Kidney Dis. 79, 868\u2013876 (2022). https:\/\/doi.org\/10.1053\/j.ajkd.2021.09.017","journal-title":"Am. J. Kidney Dis."},{"key":"4475_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1681\/ASN.2022020173","volume":"33","author":"F Locatelli","year":"2022","unstructured":"F. Locatelli, Del L. Vecchio, The search for the perfect agent for anemia management in chronic kidney disease. J. Am. Soc. Nephrol. 33, 662\u2013664 (2022). https:\/\/doi.org\/10.1681\/ASN.2022020173","journal-title":"J. Am. Soc. Nephrol."},{"key":"4475_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","volume":"381","author":"N Chen","year":"2019","unstructured":"N. Chen, C. Hao, B.C. Liu, H. Lin, C. Wang, C. Xing et al., Roxadustat treatment for anemia in patients undergoing Long-Term Dialysis. N Engl. J. Med. 381, 1011\u20131022 (2019). https:\/\/doi.org\/10.1056\/NEJMoa1901713","journal-title":"N Engl. J. Med."},{"key":"4475_CR5","doi-asserted-by":"publisher","unstructured":"T. Akizawa, M. Iwasaki, Y. Yamaguchi, Y. Majikawa, M. Reusch, Phase, 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan. J Am Soc Nephrol. 31, 1628-39 (2020). https:\/\/doi.org\/10.1681\/ASN.2019060623","DOI":"10.1681\/ASN.2019060623"},{"key":"4475_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/jbmr.3314","volume":"33","author":"AK Yadav","year":"2018","unstructured":"A.K. Yadav, V. Kumar, V. Kumar, D. Banerjee, K.L. Gupta, V. Jha, The effect of vitamin D supplementation on bone metabolic markers in chronic kidney disease. J. Bone Min. Res. 33, 404\u2013409 (2018)","journal-title":"J. Bone Min. Res."},{"key":"4475_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/kisup.2013.91","volume":"3","author":"S Fukuma","year":"2013","unstructured":"S. Fukuma, N. Kurita, M. Fukagawa, T. Akizawa, S. Fukuhara, Impact of Cinacalcet introduction on MBD management: the MBD-5D study in Japan. Kidney Int. Suppl. 3, 436\u2013441 (2013)","journal-title":"Kidney Int. Suppl."},{"key":"4475_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bone.2011.12.003","volume":"50","author":"Q Zhao","year":"2012","unstructured":"Q. Zhao, X. Shen, W. Zhang, G. Zhu, J. Qi, L. Deng, Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. Bone. 50, 763\u2013770 (2012)","journal-title":"Bone"},{"key":"4475_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13287-020-02112-9","volume":"12","author":"L Yi","year":"2021","unstructured":"L. Yi, Y. Ju, Y. He, X. Yin, Y. Xu, T. Weng, Intraperitoneal injection of Desferal\u00ae alleviated the age-related bone loss and senescence of bone marrow stromal cells in rats. Stem Cell. Res. Ther. 12, 45 (2021)","journal-title":"Stem Cell. Res. Ther."},{"key":"4475_CR10","doi-asserted-by":"crossref","unstructured":"C.S. Devignes, Y. Aslan, A. Brenot, A. Devillers, K. Schepers, S. Fabre et al., HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice. Proc. Natl. Acad. Sci. U S A . 115, E992-e1001 (2018)","DOI":"10.1073\/pnas.1718009115"},{"key":"4475_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"J. Liu, Q. Xiao, J. Xiao, C. Niu, Y. Li, X. Zhang et al., Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal. Transduct. Target. Ther. 7, 3 (2022). https:\/\/doi.org\/10.1038\/s41392-021-00762-6","journal-title":"Signal. Transduct. Target. Ther."},{"key":"4475_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12020-022-03199-1","volume":"79","author":"L Li","year":"2023","unstructured":"L. Li, A. Li, L. Gan, L. Zuo, Roxadustat improves renal osteodystrophy by dual regulation of bone remodeling. Endocrine. 79, 180\u2013189 (2023)","journal-title":"Endocrine"},{"key":"4475_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1479-5876-11-201","volume":"11","author":"G Wheater","year":"2013","unstructured":"G. Wheater, M. Elshahaly, S.P. Tuck, H.K. Datta, van J.M. Laar, The clinical utility of bone marker measurements in osteoporosis. J. Transl Med. 11, 201 (2013)","journal-title":"J. Transl Med."},{"key":"4475_CR14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.clinbiochem.2009.04.001","volume":"42","author":"JP Brown","year":"2009","unstructured":"J.P. Brown, C. Albert, B.A. Nassar, J.D. Adachi, D. Cole, K.S. Davison et al., Bone turnover markers in the management of postmenopausal osteoporosis. Clin. Biochem. 42, 929\u2013942 (2009)","journal-title":"Clin. Biochem."},{"key":"4475_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","volume":"63","author":"MB Greenblatt","year":"2017","unstructured":"M.B. Greenblatt, J.N. Tsai, M.N. Wein, Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin. Chem. 63, 464\u2013474 (2017)","journal-title":"Clin. Chem."},{"key":"4475_CR16","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1113\/jphysiol.2014.273979","volume":"592","author":"E Lederer","year":"2014","unstructured":"E. Lederer, Regulation of serum phosphate. J. Physiol. 592, 3985\u20133995 (2014)","journal-title":"J. Physiol."},{"key":"4475_CR17","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1038\/s41598-023-30331-6","volume":"13","author":"S Yoshida","year":"2023","unstructured":"S. Yoshida, T. Saito, K. Shibagaki, K. Hirao, T. Yuza, N. Tomosugi et al., Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with Roxadustat in patients on Hemodialysis. Sci. Rep. 13, 3181 (2023)","journal-title":"Sci. Rep."},{"key":"4475_CR18","doi-asserted-by":"crossref","unstructured":"J. Silver, T. Naveh-Many, FGF23 and the parathyroid. Adv Exp Med Biol. 728, 92\u2009\u2013\u20099 (2012)","DOI":"10.1007\/978-1-4614-0887-1_6"},{"key":"4475_CR19","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00198-022-06462-3","volume":"33","author":"M Abdalbary","year":"2022","unstructured":"M. Abdalbary, M. Sobh, S. Elnagar, M.A. Elhadedy, N. Elshabrawy, M. Abdelsalam et al., Management of osteoporosis in patients with chronic kidney disease. Osteoporos. Int. 33, 2259\u20132274 (2022)","journal-title":"Osteoporos. Int."},{"key":"4475_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","volume":"278","author":"AB Reiss","year":"2018","unstructured":"A.B. Reiss, N. Miyawaki, J. Moon, L.J. Kasselman, I. Voloshyna, R. Jr. D\u2019Avino et al., CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis. 278, 49\u201359 (2018)","journal-title":"Atherosclerosis"},{"key":"4475_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000315864","volume":"32","author":"H Sugiura","year":"2010","unstructured":"H. Sugiura, T. Yoshida, M. Mitobe, S. Shiohira, K. Nitta, K. Tsuchiya, Recombinant human erythropoietin mitigates reductions in renal Klotho expression. Am. J. Nephrol. 32, 137\u2013144 (2010)","journal-title":"Am. J. Nephrol."},{"key":"4475_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jbmr.4272","volume":"36","author":"ML Noonan","year":"2021","unstructured":"M.L. Noonan, P. Ni, R. Agoro, S.A. Sacks, E.A. Swallow, J.A. Wheeler et al., The HIF-PHI BAY 85-3934 (Molidustat) improves anemia and is associated with reduced levels of Circulating FGF23 in a CKD mouse model. J. Bone Min. Res. 36, 1117\u20131130 (2021)","journal-title":"J. Bone Min. Res."},{"key":"4475_CR23","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/gerona\/glu170","volume":"70","author":"P Buend\u00eda","year":"2015","unstructured":"P. Buend\u00eda, J. Carracedo, S. Soriano, J.A. Madue\u00f1o, A. Ortiz, A. Mart\u00edn-Malo et al., Klotho prevents NF\u03baB translocation and protects endothelial cell from senescence induced by uremia. J. Gerontol. Biol. Sci. Med. Sci. 70, 1198\u20131209 (2015)","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"4475_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/ALN.0000000000001163","volume":"125","author":"HD Kiers","year":"2016","unstructured":"H.D. Kiers, G.J. Scheffer, van der J.G. Hoeven, H.K. Eltzschig, P. Pickkers, M. Kox, Immunologic consequences of hypoxia during critical illness. Anesthesiology. 125, 237\u2013249 (2016)","journal-title":"Anesthesiology"},{"key":"4475_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2022.04.002","volume":"124","author":"T Yoshida","year":"2022","unstructured":"T. Yoshida, T. Okumura, Y. Matsuo, T. Okuyama, T. Michiura, M. Kaibori et al., Activation of transcription factor HIF inhibits IL-1\u03b2-induced NO production in primary cultured rat hepatocytes. Nitric Oxide. 124, 1\u201314 (2022)","journal-title":"Nitric Oxide"},{"key":"4475_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2007.09.033","volume":"134","author":"A Robinson","year":"2008","unstructured":"A. Robinson, S. Keely, J. Karhausen, M.E. Gerich, G.T. Furuta, S.P. Colgan, Mucosal protection by hypoxia-inducible factor Prolyl hydroxylase Inhibition. Gastroenterology. 134, 145\u2013155 (2008)","journal-title":"Gastroenterology"},{"key":"4475_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1042\/CS20171625","volume":"132","author":"Y Yang","year":"2018","unstructured":"Y. Yang, X. Yu, Y. Zhang, G. Ding, C. Zhu, S. Huang et al., Hypoxia-inducible factor Prolyl hydroxylase inhibitor Roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury. Clin. Sci. (Lond). 132, 825\u2013838 (2018)","journal-title":"Clin. Sci. (Lond)"},{"key":"4475_CR28","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3390\/ijms24043772","volume":"24","author":"T Iantomasi","year":"2015","unstructured":"T. Iantomasi, C. Romagnoli, G. Palmini, S. Donati, I. Falsetti, F. Miglietta et al., Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with MicroRNAs. Int. J. Mol. Sci. 24, 3772 (2015)","journal-title":"Int. J. Mol. Sci."},{"key":"4475_CR29","doi-asserted-by":"publisher","first-page":"9382","DOI":"10.1074\/jbc.M117.788562","volume":"292","author":"S Hwang","year":"2017","unstructured":"S. Hwang, A.D. Nguyen, Y. Jo, L.J. Engelking, J. Brugarolas, R.A. DeBose-Boyd, Hypoxia-inducible factor 1\u03b1 activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver. J. Biol. Chem. 292, 9382\u20139393 (2017)","journal-title":"J. Biol. Chem."},{"key":"4475_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/cells8030214","volume":"8","author":"I Mylonis","year":"2019","unstructured":"I. Mylonis, G. Simos, E. Paraskeva, Hypoxia-Inducible factors and the regulation of lipid metabolism. Cells. 8, 214 (2019). https:\/\/doi.org\/10.3390\/cells8030214","journal-title":"Cells"},{"key":"4475_CR31","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1210\/clinem\/dgad483","volume":"109","author":"T Haraguchi","year":"2023","unstructured":"T. Haraguchi, Y. Hamamoto, H. Kuwata, Y. Yamazaki, S. Nakatani, T. Hyo et al., Effect of Roxadustat on thyroid function in patients with renal anemia. J. Clin. Endocrinol. Metab. 109, e69\u2013e75 (2023)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4475_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2020111638","volume":"33","author":"S Fishbane","year":"2022","unstructured":"S. Fishbane, C.A. Pollock, M. El-Shahawy, E.T. Escudero, A. Rastogi, B.P. Van et al., Roxadustat versus Epoetin Alfa for treating anemia in patients with chronic kidney disease on dialysis: results from the randomized phase 3 ROCKIES study. J. Am. Soc. Nephrol. 33, 850\u2013866 (2022)","journal-title":"J. Am. Soc. Nephrol."},{"key":"4475_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells10010089","volume":"10","author":"H Kim","year":"2021","unstructured":"H. Kim, B. Oh, K.H. Park-Min, Regulation of osteoclast differentiation and activity by lipid metabolism. Cells. 10, 89 (2021). https:\/\/doi.org\/10.3390\/cells10010089","journal-title":"Cells"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04475-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:05:23Z","timestamp":1767013523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04475-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of Helsinki Declaration. This study was approved by the Medical Ethics Committee of The Affiliated Hospital of Nanjing University Medical School [Ethics No. 2025-0026-02]. This study has obtained consent from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"10"}}